Vivani Medical VANI Increase Decrease In Research And Development Tax Incentive Receivable
Increase Decrease In Research And Development Tax Incentive Receivable at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept vani:IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable.
The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's increase decrease in research and development tax incentive receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's increase decrease in research and development tax incentive receivable?
- Vivani Medical (VANI) reported increase decrease in research and development tax incentive receivable of $43K in Q1 2026.
- How has Vivani Medical's increase decrease in research and development tax incentive receivable changed year-over-year?
- Vivani Medical's increase decrease in research and development tax incentive receivable increased by 155.1% year-over-year, from -$78K to $43K.
- What does increase decrease in research and development tax incentive receivable mean?
- This metric tracks the change in receivables related to government or third-party research and development tax incentives. It reflects the timing difference between incurring qualifying R&D expenses and the actual collection of associated tax credits or grants.